{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:19:09Z","timestamp":1790756349721,"version":"4.1.0"},"reference-count":124,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,12,31]],"date-time":"2018-12-31T00:00:00Z","timestamp":1546214400000},"content-version":"vor","delay-in-days":364,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2018]]},"DOI":"10.6061\/clinics\/2018\/e539s","type":"journal-article","created":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T09:51:58Z","timestamp":1539683518000},"page":"e539s","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"S1","title":["Human papillomavirus and genome instability: from productive infection to cancer"],"prefix":"10.1016","volume":"73","author":[{"given":"Bruna","family":"Prati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna","family":"Marangoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Boccardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.6061\/clinics\/2018\/e539s_bib1","author":"International Agency for Research on Cancer"},{"issue":"1","key":"10.6061\/clinics\/2018\/e539s_bib2","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.virol.2010.02.002","article-title":"Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments","volume":"401","author":"Bernard","year":"2010","journal-title":"Virology"},{"issue":"2","key":"10.6061\/clinics\/2018\/e539s_bib3","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.virol.2008.11.046","article-title":"Papillomaviruses in the causation of human cancers - a brief historical account","volume":"384","author":"zur Hausen","year":"2009","journal-title":"Virology"},{"key":"10.6061\/clinics\/2018\/e539s_bib4","series-title":"Vaccines for the Prevention of Cervical Cancer [Internet]","article-title":"HPV and genital cancer: the essential epidemiology","author":"Bosch","year":"2008"},{"issue":"Suppl 3","key":"10.6061\/clinics\/2018\/e539s_bib5","first-page":"S3\/11","article-title":"Chapter 2: The burden of HPV-related cancers","volume":"24","author":"Parkin","year":"2006","journal-title":"Vaccine"},{"issue":"26","key":"10.6061\/clinics\/2018\/e539s_bib6","doi-asserted-by":"crossref","first-page":"10516","DOI":"10.1073\/pnas.1202684109","article-title":"A discrete population of squamocolumnar junction cells implicated in the pathogenesis of cervical cancer","volume":"109","author":"Herfs","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.6061\/clinics\/2018\/e539s_bib7","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nrc2886","article-title":"Human papillomavirus oncoproteins: pathways to transformation","volume":"10","author":"Moody","year":"2010","journal-title":"Nat Rev Cancer"},{"issue":"Suppl 1","key":"10.6061\/clinics\/2018\/e539s_bib8","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.jcv.2004.12.006","article-title":"The papillomavirus life cycle","volume":"32","author":"Doorbar","year":"2005","journal-title":"J Clin Virol"},{"issue":"21","key":"10.6061\/clinics\/2018\/e539s_bib9","doi-asserted-by":"crossref","first-page":"11451","DOI":"10.1128\/JVI.78.21.11451-11460.2004","article-title":"Mechanisms of human papillomavirus-induced oncogenesis","volume":"78","author":"M\u00fcnger","year":"2004","journal-title":"J Virol"},{"issue":"1","key":"10.6061\/clinics\/2018\/e539s_bib10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.virol.2013.04.022","article-title":"HPV 5 and 8 E6 expression reduces ATM protein levels and attenuates LINE-1 retrotransposition","volume":"443","author":"Wallace","year":"2013","journal-title":"Virology"},{"issue":"Suppl 1","key":"10.6061\/clinics\/2018\/e539s_bib11","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.ypmed.2011.08.017","article-title":"Epidemiology and burden of HPV infection and related diseases: implications for prevention strategies","volume":"53","author":"Tota","year":"2011","journal-title":"Prev Med"},{"issue":"6422","key":"10.6061\/clinics\/2018\/e539s_bib12","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/362709a0","article-title":"Instability and decay of the primary structure of DNA","volume":"362","author":"Lindahl","year":"1993","journal-title":"Nature"},{"issue":"4","key":"10.6061\/clinics\/2018\/e539s_bib13","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nrm2351","article-title":"Regulation of DNA repair throughout the cell cycle","volume":"9","author":"Branzei","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"10","key":"10.6061\/clinics\/2018\/e539s_bib14","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nrc3344","article-title":"Crosstalk between chromatin state and DNA damage response in cellular senescence and cancer","volume":"12","author":"Sulli","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.6061\/clinics\/2018\/e539s_bib15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1146\/annurev.biochem.73.011303.073723","article-title":"Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints","volume":"73","author":"Sancar","year":"2004","journal-title":"Annu Rev Biochem"},{"issue":"6811","key":"10.6061\/clinics\/2018\/e539s_bib16","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/35044005","article-title":"The DNA damage response: putting checkpoints inperspective","volume":"408","author":"Zhou","year":"2000","journal-title":"Nature"},{"issue":"10","key":"10.6061\/clinics\/2018\/e539s_bib17","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1093\/carcin\/bgg137","article-title":"ATM, ATR and DNA-PK: initiators of the cellular genotoxic stress responses","volume":"24","author":"Yang","year":"2003","journal-title":"Carcinogenesis"},{"issue":"17","key":"10.6061\/clinics\/2018\/e539s_bib18","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1101\/gad.914401","article-title":"Cell cycle checkpoint signaling through the ATM and ATR kinases","volume":"15","author":"Abraham","year":"2001","journal-title":"Genes Dev"},{"issue":"1","key":"10.6061\/clinics\/2018\/e539s_bib19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0959-437X(99)00050-7","article-title":"Sensing and responding to DNA damage","volume":"10","author":"Lowndes","year":"2000","journal-title":"Curr Opin Genet Dev"},{"issue":"10","key":"10.6061\/clinics\/2018\/e539s_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000605","article-title":"Human papillomaviruses activate the ATM DNA damage pathway for viral genome amplification upon differentiation","volume":"5","author":"Moody","year":"2009","journal-title":"PLoS Pathog"},{"issue":"7","key":"10.6061\/clinics\/2018\/e539s_bib21","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1128\/JVI.03473-12","article-title":"Human papillomavirus episome stability is reduced by aphidicolin and controlled by DNA damage response pathways","volume":"87","author":"Edwards","year":"2013","journal-title":"J Virol"},{"issue":"6","key":"10.6061\/clinics\/2018\/e539s_bib22","doi-asserted-by":"crossref","first-page":"e02006","DOI":"10.1128\/mBio.02006-15","article-title":"STAT-5 Regulates Transcription of the Topoisomerase II&bgr;-Binding Protein 1 (TopBP1) Gene To Activate the ATR Pathway and Promote Human Papillomavirus Replication","volume":"6","author":"Hong","year":"2015","journal-title":"MBio"},{"issue":"25","key":"10.6061\/clinics\/2018\/e539s_bib23","doi-asserted-by":"crossref","first-page":"22297","DOI":"10.1074\/jbc.M202163200","article-title":"A Functional interaction between the human papillomavirus 16 transcription\/replication factor E2 and the DNA damage response protein TopBP1","volume":"277","author":"Boner","year":"2002","journal-title":"J Biol Chem"},{"issue":"17","key":"10.6061\/clinics\/2018\/e539s_bib24","doi-asserted-by":"crossref","first-page":"9520","DOI":"10.1128\/JVI.00247-12","article-title":"Human papillomaviruses recruit cellular DNA repair and homologous recombination factors to viral replication centers","volume":"86","author":"Gillespie","year":"2012","journal-title":"J Virol"},{"issue":"4","key":"10.6061\/clinics\/2018\/e539s_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000397","article-title":"Mechanism of genomic instability in cells infected with the high-risk human papillomaviruses","volume":"5","author":"Kadaja","year":"2009","journal-title":"PLoS Pathog"},{"issue":"2","key":"10.6061\/clinics\/2018\/e539s_bib26","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1128\/JVI.01943-12","article-title":"Engagement of the ATR-dependent DNA damage response at the human papillomavirus 18 replication centers during the initial amplification","volume":"87","author":"Reinson","year":"2013","journal-title":"J Virol"},{"issue":"17","key":"10.6061\/clinics\/2018\/e539s_bib27","doi-asserted-by":"crossref","first-page":"8981","DOI":"10.1128\/JVI.00541-11","article-title":"The papillomavirus E1 helicase activates a cellular DNA damage response in viral replication foci","volume":"85","author":"Sakakibara","year":"2011","journal-title":"J Virol"},{"issue":"2","key":"10.6061\/clinics\/2018\/e539s_bib28","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1128\/JVI.73.2.1001-1009.1999","article-title":"Human papillomavirus DNA replication compartments in a transient DNA replication system","volume":"73","author":"Swindle","year":"1999","journal-title":"J Virol"},{"issue":"17","key":"10.6061\/clinics\/2018\/e539s_bib29","doi-asserted-by":"crossref","first-page":"9520","DOI":"10.1128\/JVI.00247-12","article-title":"Human papillomaviruses recruit cellular DNA repair and homologous recombination factors to viral replication centers","volume":"86","author":"Gillespie","year":"2012","journal-title":"J Virol"},{"issue":"17","key":"10.6061\/clinics\/2018\/e539s_bib30","doi-asserted-by":"crossref","first-page":"15473","DOI":"10.1074\/jbc.M110.197574","article-title":"Human papillomavirus (HPV) E7 induces prolonged G2 following S phase reentry in differentiated human keratinocytes","volume":"286","author":"Banerjee","year":"2011","journal-title":"J Biol Chem"},{"issue":"23","key":"10.6061\/clinics\/2018\/e539s_bib31","doi-asserted-by":"crossref","first-page":"12513","DOI":"10.1073\/pnas.97.23.12513","article-title":"Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways","volume":"97","author":"Goodwin","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.6061\/clinics\/2018\/e539s_bib32","doi-asserted-by":"crossref","first-page":"e00616","DOI":"10.1128\/mBio.00628-16","article-title":"Loss of Dependence on Continued Expression of the Human Papillomavirus 16 E7 Oncogene in Cervical Cancers and Precancerous Lesions Arising in Fanconi Anemia Pathway-Deficient Mice","volume":"7","author":"Park","year":"2016","journal-title":"MBio"},{"issue":"6","key":"10.6061\/clinics\/2018\/e539s_bib33","doi-asserted-by":"crossref","first-page":"E990","DOI":"10.1073\/pnas.1615758114","article-title":"Induction of dormancy in hypoxic human papillomavirus-positive cancer cells","volume":"114","author":"Hoppe-Seyler","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.6061\/clinics\/2018\/e539s_bib34","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1128\/jvi.66.4.2125-2134.1992","article-title":"The E6 and E7 genes of human papillomavirus type 6 have weak immortalizing activity in human epithelial cells","volume":"66","author":"Halbert","year":"1992","journal-title":"J Virol"},{"issue":"23","key":"10.6061\/clinics\/2018\/e539s_bib35","first-page":"7075","article-title":"The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability","volume":"62","author":"Duensing","year":"2002","journal-title":"Cancer Res"},{"issue":"3","key":"10.6061\/clinics\/2018\/e539s_bib36","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/0092-8674(91)90529-8","article-title":"Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation","volume":"67","author":"Crook","year":"1991","journal-title":"Cell"},{"issue":"8","key":"10.6061\/clinics\/2018\/e539s_bib37","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1002\/j.1460-2075.1992.tb05375.x","article-title":"Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53-mediated repression of transcription","volume":"11","author":"Lechner","year":"1992","journal-title":"EMBO J"},{"issue":"3","key":"10.6061\/clinics\/2018\/e539s_bib38","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0092-8674(93)90384-3","article-title":"The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53","volume":"75","author":"Scheffner","year":"1993","journal-title":"Cell"},{"issue":"18","key":"10.6061\/clinics\/2018\/e539s_bib39","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1093\/emboj\/18.18.5061","article-title":"The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300","volume":"18","author":"Patel","year":"1999","journal-title":"EMBO J"},{"issue":"6569","key":"10.6061\/clinics\/2018\/e539s_bib40","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/380079a0","article-title":"Telomerase activation by the E6 gene product of human papillomavirus type 16","volume":"380","author":"Klingelhutz","year":"1996","journal-title":"Nature"},{"issue":"6-7","key":"10.6061\/clinics\/2018\/e539s_bib41","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1600-0463.2010.02618.x","article-title":"Interaction of viral oncoproteins with cellular target molecules: infection with high-risk vs low-risk human papillomaviruses","volume":"118","author":"Pim","year":"2010","journal-title":"APMIS"},{"issue":"1","key":"10.6061\/clinics\/2018\/e539s_bib42","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/j.1460-2075.1990.tb08091.x","article-title":"The region of the HPV E7 oncoprotein homologous to adenovirus E1a and Sv40 large T antigen contains separate domains for Rb binding and casein kinase II phosphorylation","volume":"9","author":"Barbosa","year":"1990","journal-title":"EMBO J"},{"issue":"4893","key":"10.6061\/clinics\/2018\/e539s_bib43","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1126\/science.2537532","article-title":"The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product","volume":"243","author":"Dyson","year":"1989","journal-title":"Science"},{"issue":"15","key":"10.6061\/clinics\/2018\/e539s_bib44","doi-asserted-by":"crossref","first-page":"6737","DOI":"10.1128\/JVI.75.15.6737-6747.2001","article-title":"Destabilization of the retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes","volume":"75","author":"Helt","year":"2001","journal-title":"J Virol"},{"issue":"6","key":"10.6061\/clinics\/2018\/e539s_bib45","doi-asserted-by":"crossref","first-page":"722","DOI":"10.3349\/ymj.2002.43.6.722","article-title":"Alteration of cell cycle in cervical tumor associated with human papillomavirus: cyclin-dependent kinase inhibitors","volume":"43","author":"Cho","year":"2002","journal-title":"Yonsei Med J"},{"issue":"9","key":"10.6061\/clinics\/2018\/e539s_bib46","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1093\/emboj\/18.9.2449","article-title":"The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth","volume":"18","author":"Brehm","year":"1999","journal-title":"EMBO J"},{"issue":"7","key":"10.6061\/clinics\/2018\/e539s_bib47","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1128\/JVI.78.7.3533-3541.2004","article-title":"The binding of histone deacetylases and the integrity of zinc finger-like motifs of the E7 protein are essential for the life cycle of human papillomavirus type 31","volume":"78","author":"Longworth","year":"2004","journal-title":"J Virol"},{"issue":"9","key":"10.6061\/clinics\/2018\/e539s_bib48","first-page":"3837","article-title":"Human papillomavirus type 16 E6 and E7 cooperate to increase epidermal growth factor receptor (EGFR) mRNA levels, overcoming mechanisms by which excessive EGFR signaling shortens the life span of normal human keratinocytes","volume":"61","author":"Akerman","year":"2001","journal-title":"Cancer Res"},{"issue":"18","key":"10.6061\/clinics\/2018\/e539s_bib49","doi-asserted-by":"crossref","first-page":"10002","DOI":"10.1073\/pnas.170093297","article-title":"The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle","volume":"97","author":"Duensing","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.6061\/clinics\/2018\/e539s_bib50","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1128\/JVI.74.6.2679-2686.2000","article-title":"Repression of the integrated papillomavirus E6\/E7 promoter is required for growth suppression of cervical cancer cells","volume":"74","author":"Francis","year":"2000","journal-title":"J Virol"},{"issue":"15","key":"10.6061\/clinics\/2018\/e539s_bib51","first-page":"4289","article-title":"Human papillomavirus type 16 E6 and E7 proteins inhibit differentiation-dependent expression of transforming growth factor-beta2 in cervical keratinocytes","volume":"60","author":"Nees","year":"2000","journal-title":"Cancer Res"},{"issue":"2","key":"10.6061\/clinics\/2018\/e539s_bib52","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1006\/viro.2001.1263","article-title":"Inhibition of serum- and calcium-induced terminal differentiation of human keratinocytes by HPV 16 E6: study of the association with p53 degradation, inhibition of p53 transactivation, and binding to E6BP","volume":"292","author":"Sherman","year":"2002","journal-title":"Virology"},{"issue":"2","key":"10.6061\/clinics\/2018\/e539s_bib53","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1128\/JVI.72.2.1131-1137.1998","article-title":"Human papillomavirus oncoproteins E6 and E7 independently abrogate the mitotic spindle checkpoint","volume":"72","author":"Thomas","year":"1998","journal-title":"J Virol"},{"issue":"2","key":"10.6061\/clinics\/2018\/e539s_bib54","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.virol.2008.10.006","article-title":"The human papillomavirus E7 oncoprotein","volume":"384","author":"McLaughlin-Drubin","year":"2009","journal-title":"Virology"},{"issue":"5","key":"10.6061\/clinics\/2018\/e539s_bib55","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1073\/pnas.95.5.2290","article-title":"Human papillomavirus type 16 E6 and E7 oncogenes abrogate radiation-induced DNA damage responses in vivo through p53-dependent and p53-independent pathways","volume":"95","author":"Song","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.6061\/clinics\/2018\/e539s_bib56","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.radonc.2014.08.026","article-title":"Human papillomavirus type 16 E7 oncoprotein causes a delay in repair of DNA damage","volume":"113","author":"Park","year":"2014","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.6061\/clinics\/2018\/e539s_bib57","first-page":"427","article-title":"Expression of HPV16 E6 or E7 increases integration of foreign DNA","volume":"13","author":"Kessis","year":"1996","journal-title":"Oncogene"},{"issue":"17","key":"10.6061\/clinics\/2018\/e539s_bib58","doi-asserted-by":"crossref","first-page":"7022","DOI":"10.1158\/0008-5472.CAN-09-0925","article-title":"Human papillomavirus 16 E7 oncoprotein attenuates DNA damage checkpoint control by increasing the proteolytic turnover of claspin","volume":"69","author":"Spardy","year":"2009","journal-title":"Cancer Res"},{"issue":"7","key":"10.6061\/clinics\/2018\/e539s_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002807","article-title":"HPV 5 and 8 E6 abrogate ATR activity resulting in increased persistence of UVB induced DNA damage","volume":"8","author":"Wallace","year":"2012","journal-title":"PLoS Pathog"},{"issue":"39","key":"10.6061\/clinics\/2018\/e539s_bib60","doi-asserted-by":"crossref","first-page":"33165","DOI":"10.1074\/jbc.M505124200","article-title":"BRCA1 interaction with human papillomavirus oncoproteins","volume":"280","author":"Zhang","year":"2005","journal-title":"J Biol Chem"},{"issue":"50","key":"10.6061\/clinics\/2018\/e539s_bib61","doi-asserted-by":"crossref","first-page":"6997","DOI":"10.1038\/sj.onc.1203180","article-title":"Impaired nucleotide excision repair in UV-irradiated human oral keratinocytes immortalized with type 16 human papillomavirus genome","volume":"18","author":"Rey","year":"1999","journal-title":"Oncogene"},{"issue":"26","key":"10.6061\/clinics\/2018\/e539s_bib62","doi-asserted-by":"crossref","first-page":"15038","DOI":"10.1073\/pnas.96.26.15038","article-title":"Human cells compromised for p53 function exhibit defective global and transcription-coupled nucleotide excision repair, whereas cells compromised for pRb function are defective only in global repair","volume":"96","author":"Therrien","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"18","key":"10.6061\/clinics\/2018\/e539s_bib63","doi-asserted-by":"crossref","first-page":"29963","DOI":"10.18632\/oncotarget.16265","article-title":"Misregulation of DNA damage repair pathways in HPV-positive head and neck squamous cell carcinoma contributes to cellular radiosensitivity","volume":"8","author":"Nickson","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.6061\/clinics\/2018\/e539s_bib64","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0921-8777(99)00066-X","article-title":"p53-degradation by HPV-16 E6 preferentially affects the removal of cyclobutane pyrimidine dimers from non-transcribed strand and sensitizes mammary epithelial cells to UV-irradiation","volume":"459","author":"El-Mahdy","year":"2000","journal-title":"Mutat Res"},{"issue":"11","key":"10.6061\/clinics\/2018\/e539s_bib65","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1038\/sj.bjc.6601829","article-title":"Repair of UV-induced thymine dimers is compromised in cells expressing the E6 protein from human papillomaviruses types 5 and 18","volume":"90","author":"Giampieri","year":"2004","journal-title":"Br J Cancer"},{"issue":"1","key":"10.6061\/clinics\/2018\/e539s_bib66","first-page":"209","article-title":"HPV-16 E6 oncoprotein impairs the fidelity of DNA end-joining via p53-dependent and-independent pathways","volume":"28","author":"Shin","year":"2006","journal-title":"Int J Oncol"},{"issue":"38","key":"10.6061\/clinics\/2018\/e539s_bib67","doi-asserted-by":"crossref","first-page":"5940","DOI":"10.1038\/sj.onc.1205762","article-title":"The DNA repair protein, O(6)-methylguanine-DNA methyltransferase is a proteolytic target for the E6 human papillomavirusoncoprotein","volume":"21","author":"Srivenugopal","year":"2002","journal-title":"Oncogene"},{"issue":"17","key":"10.6061\/clinics\/2018\/e539s_bib68","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.1093\/emboj\/cdf443","article-title":"Interference of papillomavirus E6 protein with single-strand break repair byinteraction with XRCC1","volume":"21","author":"Iftner","year":"2002","journal-title":"EMBO J"},{"issue":"5","key":"10.6061\/clinics\/2018\/e539s_bib69","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"2","key":"10.6061\/clinics\/2018\/e539s_bib70","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.virol.2008.10.004","article-title":"Interaction of human papillomaviruses with the host immune system: a well evolved relationship","volume":"384","author":"Frazer","year":"2009","journal-title":"Virology"},{"issue":"Pt 6","key":"10.6061\/clinics\/2018\/e539s_bib71","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1042\/BST0351456","article-title":"HPV: from infection to cancer","volume":"35","author":"Stanley","year":"2007","journal-title":"Biochem Soc Trans"},{"key":"10.6061\/clinics\/2018\/e539s_bib72","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-genet-102108-134222","article-title":"How the fanconi anemia pathway guards the genome","volume":"43","author":"Moldovan","year":"2009","journal-title":"Annu Rev Genet"},{"issue":"23","key":"10.6061\/clinics\/2018\/e539s_bib73","doi-asserted-by":"crossref","first-page":"13265","DOI":"10.1128\/JVI.01121-07","article-title":"The human papillomavirus type 16 E7 oncoprotein activates the Fanconi anemia (FA) pathway and causes accelerated chromosomal instability in FA cells","volume":"81","author":"Spardy","year":"2007","journal-title":"J Virol"},{"issue":"23","key":"10.6061\/clinics\/2018\/e539s_bib74","doi-asserted-by":"crossref","first-page":"9959","DOI":"10.1158\/0008-5472.CAN-10-1291","article-title":"Deficiencies in the Fanconi anemia DNA damage response pathway increase sensitivity to HPV-associated head and neck cancer","volume":"70","author":"Park","year":"2010","journal-title":"Cancer Res"},{"issue":"1-2","key":"10.6061\/clinics\/2018\/e539s_bib75","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11010-013-1569-y","article-title":"Decreased expression of DNA repair genes (XRCC1, ERCC1, ERCC2, and ERCC4) in squamous intraepithelial lesion and invasive squamous cell carcinoma of the cervix","volume":"377","author":"Bajpai","year":"2013","journal-title":"Mol Cell Biochem"},{"issue":"3","key":"10.6061\/clinics\/2018\/e539s_bib76","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1158\/1078-0432.CCR-13-3310","article-title":"Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas","volume":"21","author":"Seiwert","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.6061\/clinics\/2018\/e539s_bib77","series-title":"Express&atilde;o de genes de vias de reparo de dano ao DNA em c&eacute;lulas infectadas por papilomav&iacute;rus humano (HPV). Disserta\u00e7\u00e3o de Mestrado","author":"Prati","year":"2014"},{"issue":"1-3","key":"10.6061\/clinics\/2018\/e539s_bib78","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000290657","article-title":"HPV-mediated genome instability: at the roots of cervical carcinogenesis","volume":"128","author":"Boccardo","year":"2010","journal-title":"Cytogenet Genome Res"},{"issue":"11","key":"10.6061\/clinics\/2018\/e539s_bib79","doi-asserted-by":"crossref","first-page":"4878","DOI":"10.1158\/0008-5472.CAN-08-4695","article-title":"Nitric oxide induces early viral transcription coincident with increased DNA damage and mutation rates in human papillomavirus-infected cells","volume":"69","author":"Wei","year":"2009","journal-title":"Cancer Res"},{"issue":"11","key":"10.6061\/clinics\/2018\/e539s_bib80","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1093\/carcin\/bgl172","article-title":"Interferon-beta treatment of cervical keratinocytes naturally infected with human papillomavirus 16 episomes promotes rapid reduction in episome numbers and emergence of latent integrants","volume":"27","author":"Herdman","year":"2006","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.6061\/clinics\/2018\/e539s_bib81","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/carcin\/bgu236","article-title":"Interferon treatment of human keratinocytes harboring extrachromosomal, persistent HPV-16 plasmid genomes induces de novo viral integration","volume":"36","author":"Lace","year":"2015","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.6061\/clinics\/2018\/e539s_bib82","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.tim.2010.10.002","article-title":"Persistence of human papillomavirus infection: keys to malignant progression","volume":"19","author":"Bodily","year":"2011","journal-title":"Trends Microbiol"},{"issue":"6","key":"10.6061\/clinics\/2018\/e539s_bib83","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1128\/JVI.02149-08","article-title":"Abrogation of the postmitotic checkpoint contributes to polyploidization in human papillomavirus E7-expressing cells","volume":"83","author":"Heilman","year":"2009","journal-title":"J Virol"},{"issue":"6","key":"10.6061\/clinics\/2018\/e539s_bib84","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1158\/0008-5472.CAN-06-3436","article-title":"p53-independent abrogation of a postmitotic checkpoint contributes to human papillomavirus E6-induced polyploidy","volume":"67","author":"Liu","year":"2007","journal-title":"Cancer Res"},{"issue":"12","key":"10.6061\/clinics\/2018\/e539s_bib85","first-page":"4858","article-title":"Tetrasomy is induced by human papillomavirus type 18 E7 gene expression in keratinocyte raft cultures","volume":"61","author":"Southern","year":"2001","journal-title":"Cancer Res"},{"issue":"8","key":"10.6061\/clinics\/2018\/e539s_bib86","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/em.20478","article-title":"Centrosome overduplication, chromosomal instability, and human papillomavirus oncoproteins","volume":"50","author":"Duensing","year":"2009","journal-title":"Environ Mol Mutagen"},{"issue":"21","key":"10.6061\/clinics\/2018\/e539s_bib87","doi-asserted-by":"crossref","first-page":"8715","DOI":"10.1158\/0008-5472.CAN-08-1303","article-title":"Delocalization of the microtubule motor Dynein from mitotic spindles by the human papillomavirus E7 oncoprotein is not sufficient for induction of multipolar mitoses","volume":"68","author":"Nguyen","year":"2008","journal-title":"Cancer Res"},{"issue":"2","key":"10.6061\/clinics\/2018\/e539s_bib88","first-page":"M81","article-title":"Centrosome abnormalities, genomic instability and carcinogenic progression","volume":"1471","author":"Duensing","year":"2001","journal-title":"Biochim Biophys Acta"},{"issue":"12","key":"10.6061\/clinics\/2018\/e539s_bib89","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1038\/sj.bjc.6602237","article-title":"Genomic imbalances in 70 snap-frozen cervical squamous intraepithelial lesions: associations with lesion grade, state of the HPV16 E2 gene and clinical outcome","volume":"91","author":"Alazawi","year":"2004","journal-title":"Br J Cancer"},{"issue":"4","key":"10.6061\/clinics\/2018\/e539s_bib90","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/ijc.2910430422","article-title":"Properties of a non tumorigenic human cervical keratinocyte cell line","volume":"43","author":"Stanley","year":"1989","journal-title":"Int J Cancer"},{"issue":"3","key":"10.6061\/clinics\/2018\/e539s_bib91","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/BF03033742","article-title":"Chromosomal aberrations accumulate in polyploid cells of high-grade squamous intraepithelial lesions (HSIL)","volume":"10","author":"M\u00e9hes","year":"2004","journal-title":"Pathol Oncol Res"},{"issue":"11","key":"10.6061\/clinics\/2018\/e539s_bib92","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1136\/jcp.49.11.892","article-title":"Oncogenic human papillomaviruses and ploidy in cervical lesions","volume":"49","author":"Rihet","year":"1996","journal-title":"J Clin Pathol"},{"issue":"4","key":"10.6061\/clinics\/2018\/e539s_bib93","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1158\/0008-5472.CAN-03-3214","article-title":"Acquisition of high-level chromosomal instability is associated with integration of human papillomavirus type 16 in cervical keratinocytes","volume":"64","author":"Pett","year":"2004","journal-title":"Cancer Res"},{"key":"10.6061\/clinics\/2018\/e539s_bib94","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1476-4598-1-3","article-title":"Mapping common deleted regions on 5p15 in cervical carcinoma and their occurrence in precancerous lesions","volume":"1","author":"Arias-Pulido","year":"2002","journal-title":"Mol Cancer"},{"key":"10.6061\/clinics\/2018\/e539s_bib95","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2407-4-5","article-title":"Chromosomal amplifications, 3q gain and deletions of 2q33-q37 are the frequent genetic changes in cervical carcinoma","volume":"4","author":"Rao","year":"2004","journal-title":"BMC Cancer"},{"issue":"5","key":"10.6061\/clinics\/2018\/e539s_bib96","doi-asserted-by":"crossref","first-page":"604","DOI":"10.2353\/jmoldx.2007.070007","article-title":"Chromosomal biomarkers for detection of human papillomavirus associated genomic instability in epithelial cells of cervical cytology specimens","volume":"9","author":"Sokolova","year":"2007","journal-title":"J Mol Diagn"},{"key":"10.6061\/clinics\/2018\/e539s_bib97","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1755-8794-2-32","article-title":"Genomic profiling identifies common HPV-associated chromosomal alterations in squamous cell carcinomas of cervix and head and neck","volume":"2","author":"Wilting","year":"2009","journal-title":"BMC Med Genomics"},{"issue":"15","key":"10.6061\/clinics\/2018\/e539s_bib98","first-page":"3154","article-title":"Deletions of chromosome 3p are frequent and early events in the pathogenesis of uterine cervical carcinoma","volume":"57","author":"Wistuba","year":"1997","journal-title":"Cancer Res"},{"issue":"11","key":"10.6061\/clinics\/2018\/e539s_bib99","first-page":"2585","article-title":"Association between cyclin D1 (CCND1) gene amplification and human papillomavirus infection in human laryngeal squamous cell carcinoma","volume":"4","author":"Cattani","year":"1998","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.6061\/clinics\/2018\/e539s_bib100","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/01.qai.0000179460.61987.33","article-title":"High-resolution analysis of genomic alterations and human papillomavirus integration in anal intraepithelial neoplasia","volume":"40","author":"Gagne","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"22","key":"10.6061\/clinics\/2018\/e539s_bib101","first-page":"5465","article-title":"Integrated human papillomavirus type 16 and loss of heterozygosity at 11q22 and 18q21 in an oral carcinoma and its derivative cell line","volume":"55","author":"Steenbergen","year":"1995","journal-title":"Cancer Res"},{"issue":"6","key":"10.6061\/clinics\/2018\/e539s_bib102","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/0092-8674(90)90409-8","article-title":"The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53","volume":"63","author":"Scheffner","year":"1990","journal-title":"Cell"},{"issue":"10","key":"10.6061\/clinics\/2018\/e539s_bib103","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1128\/jvi.63.10.4417-4421.1989","article-title":"The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes","volume":"63","author":"M\u00fcnger","year":"1989","journal-title":"J Virol"},{"issue":"20","key":"10.6061\/clinics\/2018\/e539s_bib104","first-page":"4620","article-title":"E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway","volume":"56","author":"Boyer","year":"1996","journal-title":"Cancer Res"},{"issue":"3","key":"10.6061\/clinics\/2018\/e539s_bib105","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/humu.10178","article-title":"The role of TP53 in Cervical carcinogenesis","volume":"21","author":"Tommasino","year":"2003","journal-title":"Hum Mutat"},{"issue":"2","key":"10.6061\/clinics\/2018\/e539s_bib106","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.radonc.2016.02.009","article-title":"Relationships between p53 mutation, HPV status and outcome in oropharyngeal squamous cell carcinoma","volume":"118","author":"Hong","year":"2016","journal-title":"Radiother Oncol"},{"issue":"14","key":"10.6061\/clinics\/2018\/e539s_bib107","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1038\/sj.onc.1202557","article-title":"Induction of the p53-target gene GADD45 in HPV-positive cancer cells","volume":"18","author":"Butz","year":"1999","journal-title":"Oncogene"},{"issue":"4","key":"10.6061\/clinics\/2018\/e539s_bib108","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/(SICI)1097-0215(19961115)68:4<506::AID-IJC17>3.0.CO;2-2","article-title":"Cellular responses of HPV-positive cancer cells to genotoxic anti-cancer agents: repression of E6\/E7-oncogene expression and induction of apoptosis","volume":"68","author":"Butz","year":"1996","journal-title":"Int J Cancer"},{"issue":"5","key":"10.6061\/clinics\/2018\/e539s_bib109","first-page":"927","article-title":"Functional p53 protein in human papillomavirus-positive cancer cells","volume":"10","author":"Butz","year":"1995","journal-title":"Oncogene"},{"issue":"1","key":"10.6061\/clinics\/2018\/e539s_bib110","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N Engl J Med"},{"issue":"7","key":"10.6061\/clinics\/2018\/e539s_bib111","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1200\/JCO.2008.18.9043","article-title":"Phase II trial of bevacizumab in the treatment of persistent or recurrent squamous cell carcinoma of the cervix: a gynecologic oncology group study","volume":"27","author":"Monk","year":"2009","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.6061\/clinics\/2018\/e539s_bib112","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ygyno.2013.04.009","article-title":"Multicenter phase II trial of topotecan, cisplatin and bevacizumab for recurrent or persistent cervical cancer","volume":"130","author":"Zighelboim","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"19","key":"10.6061\/clinics\/2018\/e539s_bib113","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.4161\/cc.8.19.9626","article-title":"Exploiting synthetic lethal interactions for targeted cancer therapy","volume":"8","author":"Reinhardt","year":"2009","journal-title":"Cell Cycle"},{"issue":"7035","key":"10.6061\/clinics\/2018\/e539s_bib114","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/nature03443","article-title":"Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase","volume":"434","author":"Bryant","year":"2005","journal-title":"Nature"},{"issue":"7035","key":"10.6061\/clinics\/2018\/e539s_bib115","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nature03445","article-title":"Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy","volume":"434","author":"Farmer","year":"2005","journal-title":"Nature"},{"issue":"4","key":"10.6061\/clinics\/2018\/e539s_bib116","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrc2812","article-title":"PARP inhibition: PARP1 and beyond","volume":"10","author":"Rouleau","year":"2010","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"10.6061\/clinics\/2018\/e539s_bib117","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.cell.2017.03.034","article-title":"PARP Inhibitors for Cancer Therapy","volume":"169","author":"Lin","year":"2017","journal-title":"Cell"},{"issue":"7","key":"10.6061\/clinics\/2018\/e539s_bib118","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrm1963","article-title":"Poly(ADP-ribose): novel functions for an old molecule","volume":"7","author":"Schreiber","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"21","key":"10.6061\/clinics\/2018\/e539s_bib119","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1158\/0008-5472.CAN-12-2753","article-title":"Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors","volume":"72","author":"Murai","year":"2012","journal-title":"Cancer Res"},{"issue":"11","key":"10.6061\/clinics\/2018\/e539s_bib120","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1158\/2159-8290.CD-15-0714","article-title":"Homologous Recombination Deficiency: Exploiting the Fundamental Vulnerability of Ovarian Cancer","volume":"5","author":"Konstantinopoulos","year":"2015","journal-title":"Cancer Discov"},{"issue":"12","key":"10.6061\/clinics\/2018\/e539s_bib121","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1200\/JCO.2014.58.8848","article-title":"Poly (ADP-ribose) polymerase inhibitors: recent advances and future development","volume":"33","author":"Scott","year":"2015","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.6061\/clinics\/2018\/e539s_bib122","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1021\/cr900047g","article-title":"Targeting the DNA damage response in cancer","volume":"109","author":"Ljungman","year":"2009","journal-title":"Chem Rev"},{"issue":"10","key":"10.6061\/clinics\/2018\/e539s_bib123","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.ctrv.2015.10.001","article-title":"Increased radiosensitivity of HPV-positive head and neck cancers: Molecular basis and therapeutic perspectives","volume":"41","author":"Mirghani","year":"2015","journal-title":"Cancer Treat Rev"},{"issue":"2","key":"10.6061\/clinics\/2018\/e539s_bib124","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.radonc.2013.03.013","article-title":"HNSCC cell lines positive for HPV and p16 possess higher cellular radiosensitivity due to an impaired DSB repair capacity","volume":"107","author":"Rieckmann","year":"2013","journal-title":"Radiother Oncol"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222011371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222011371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:59:12Z","timestamp":1761721152000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593222011371"},"secondary":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1807-59322018000200320&lng=en&nrm=iso&tlng=en","label":"SCIELO"},{"URL":"https:\/\/www.clinicsjournal.com\/article\/human-papillomavirus-and-genome-instability-from-productive-infection-to-cancer\/","label":"CLINICS"}]},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":124,"alternative-id":["S1807593222011371"],"URL":"https:\/\/doi.org\/10.6061\/clinics\/2018\/e539s","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human papillomavirus and genome instability: from productive infection to cancer","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.6061\/clinics\/2018\/e539s","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 CLINICS. Published by Elsevier Spain","name":"copyright","label":"Copyright"}],"article-number":"e539s"}}